betulinic acid has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karna, E; Palka, JA | 1 |
| Karna, E; Palka, JA; Szoka, L | 1 |
2 other study(ies) available for betulinic acid and Endometrial Neoplasms
| Article | Year |
|---|---|
Mechanism of betulinic acid inhibition of collagen biosynthesis in human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Betulinic Acid; Blotting, Western; Cell Survival; Collagen; Endometrial Neoplasms; Extracellular Signal-Regulated MAP Kinases; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin alpha2beta1; NF-kappa B; Pentacyclic Triterpenes; Proline; Receptor, IGF Type 1; Signal Transduction; Son of Sevenless Proteins; Triterpenes; Tumor Cells, Cultured | 2009 |
Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Betulinic Acid; Cell Line, Tumor; Collagen; Dipeptidases; Dose-Response Relationship, Drug; Down-Regulation; Endometrial Neoplasms; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin alpha1; Integrin alpha2; Integrin beta1; Pentacyclic Triterpenes; Triterpenes; Vascular Endothelial Growth Factor A | 2010 |